ATLASImmuneering (IMRX) earnings date: expected January 16–22
Immuneering (IMRX) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 16–22. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on IMRX
| Last price | $3.75 (-6.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.0% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Immuneering stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 16–22 (estimate). One email the day before, with ATLAS’s read on Immuneering. You can switch it off at any time.
Alert me before IMRX reportsFree to start. Creating an account takes under a minute.
IMRX earnings at a glance
| Next report | Not announced · expected around January 16–22 (ATLAS estimate) |
|---|---|
| Last report | Oct 29, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +23.1% |
| Average move around a report | ±5.0% (last 4) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Immuneering’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Immuneering earnings history: last 5 reports
Immuneering last reported on Oct 29, 2026: EPS of -$0.37 against an estimate of -$0.29 (-27.6% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | -$0.29 | -$0.37 | -27.6% | Miss | – |
| Aug 5, 2026 | -$0.27 | -$0.27 | 0.0% | In line | +1.4% |
| May 15, 2026 | -$0.25 | -$0.21 | +16.0% | Beat | -5.3% |
| Mar 10, 2026 | -$0.27 | -$0.04 | +85.2% | Beat | +0.5% |
| Mar 6, 2026 | -$0.31 | -$0.18 | +41.9% | Beat | +12.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for IMRX
See the fair value, the probability range and the earnings history of Immuneering on its ATLAS page.
Immuneering (IMRX) stock analysisPlans from €3.99 a month.
Immuneering earnings: frequently asked questions
When is Immuneering (IMRX) next earnings date?
Immuneering has not announced its next report. Its last 4 reports came Oct 29, 2026, Aug 5, 2026, May 15, 2026, Mar 10, 2026, so ATLAS estimates the next one around January 16–22. This is an estimate based on that pattern, not a confirmed date.
How often does IMRX beat earnings estimates?
Of its last 5 reports with a recorded result, Immuneering beat the EPS estimate 3 times; the average surprise was +23.1%. Past results do not predict the next one.
How much does IMRX move around earnings?
Over its last 4 reports the stock moved an average of 5.0% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Immuneering beat earnings estimates last quarter?
Immuneering last reported on Oct 29, 2026: EPS of -$0.37 against an estimate of -$0.29 (-27.6% surprise), a miss.
How much does IMRX usually move in a day?
On a normal trading day the ATLAS model puts IMRX’s one-day range at about ±4.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer